Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-016041

President & CEO gave up 16,140 shares (to pay taxes)

  • President & CEO acquired 54,916 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KAKKIS EMIL D President & CEO 2023-03-01 Grant or award +8,716 569,406 D
KAKKIS EMIL D President & CEO 2023-03-01 Grant or award +46,200 615,606 D
KAKKIS EMIL D President & CEO 2023-03-01 Shares withheld for taxes −16,140 $45.65 $736,791 599,176 D
Derivatives
KAKKIS EMIL D President & CEO 2023-03-01 Grant or award · Stock Option (Right to Buy) +83,500 83,500 D
Loading xslF345X03/doc4.xml…